ArticleDermatology and therapy2023

Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials.

Saxon D Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.